About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

New Electrochemical Assay Can Accurately Diagnose Cancer Causing Mutations from Blood

by Vishnuprasad on June 5, 2015 at 11:10 PM
Font : A-A+

New Electrochemical Assay Can Accurately Diagnose Cancer Causing Mutations from Blood

Cell free nucleic acids (cfNA) are genetic sequences. They are not attached to cells. They can be found circulating in the blood. These acids can be used to detect mutations in genetic sequences and can thereby be used as a 'liquid biopsy' tool for diagnosis of several types of cancer.

Scientists from University of Toronto have developed a simple method of analyzing the amount of mutated cfNA present in patient blood.

Advertisement

The study details the fabrication of an electrochemical clamp assay targeted towards detecting mutations in the KRAS gene, which causes lung, colorectal and ovarian cancer. The assay works by mixing in clamps that are specific for all other mutations except the mutation of interest, leading to a solution that has only the target mutation free of clamps.

This solution is then applied to a sensor, where the target mutation binds, and is detected with the help of an electrochemical sensor. The other mutations which have been clamped are not able to bind to the sensor and are finally washed away.
Advertisement

The electrochemical clamp assay requires much less volumes of serum, and can be performed on undiluted serum, which leads to simplicity in workflow and minimized sample loss. Also, the test can produce results in as little as 5 minutes, and can cut down on significant costs involved in cancer diagnosis.



Source: Medindia
Advertisement

Advertisement
Advertisement

Recommended Reading

Latest Cancer News

 Tobacco Use Among Cancer Patients Likely to Increase Symptom Burden
A new study assessed the association of cigarette smoking and vaping on cancer-related symptom burden (fatigue, pain, emotional problems) and quality of life.
Breaking New Ground in Breast Cancer Therapy Without Chemotherapy
Scientists are making strides in personalized breast cancer therapy by developing a highly accurate molecular classifier test for breast cancer patients.
 Prostate Cancer 'Test by Request' Policies: Beneficial or Detrimental
Experts suggest high-income countries implement a comprehensive risk-based approach for prostate-specific antigen (PSA) testing to reduce overdiagnosis and overtreatment.
 Oral Cancer Cells Use Fat as Fuel to Escape from Immunity
New study identifies the role of metabolic comorbidities such as obesity in contributing to the immunogenicity of oral cancer through the immune pathway STING-IFN-I.
 Treating Anal Cancer With Smarter and Kinder Approach
Recent clinical trial results have shown that reducing the dose and duration of radiotherapy treatments for anal cancer may result in fewer side effects.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

New Electrochemical Assay Can Accurately Diagnose Cancer Causing Mutations from Blood Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests